...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Notice anything different about #11

Thanks tada, I see where you are coming from however on clinical trials.gov MSK is listed as the responsible party so it is my understanding that they are running their trial and information would flow from them (perhaps unfortunately)

Share
New Message
Please login to post a reply